Evusheld was a key antibody treatment taken by people with weak immune systems as an added layer of protection.

The CDC study provides the first estimate of the omicron shots’ real-world effectiveness against the XBB family of ...

The updated COVID-19 booster shots are at least 40% effective against symptomatic infection from omicron subvariants XBB.1.5 ...

CDC data shows the bivalent COVID vaccines protect against the omicron variant known as XBB and its subvariant XBB.1.5.

In a study released today by the Centers for Disease Control and Prevention, a single bivalent COVID-19 vaccine booster ...

Opens in a new tab or window Currently authorized bivalent COVID-19 boosters demonstrated similar protection against ...

XBB.1.5 is a spinoff of XBB, a subvariant of omicron that health officials worldwide have been warning about since the fall.

New data from the Centers for Disease Control and Prevention (CDC) indicates that the updated bivalent COVID-19 vaccines do ...

County officials cited a new study released by the Centers for Disease Control and Prevention as they continue to urge local ...

The updated Covid boosters reduce the risk of Covid infection from the predominant omicron subvariant by nearly half, ...

XBB.1.5's prevalence remains highest in ... is growing in proportion quickly," Barbara Mahon, head of the CDC's proposed Coronavirus and Other Respiratory Viruses Division, told CBS News last ...

A booster dose provided at least 3 months of protection against symptomatic XBB and XBB.1.5 infections in seniors who had ...